The Cooper Companies, Inc. (COO) has a MoatMap StockRank of 67/100 based on Quality (56/100), Value (41/100), and Momentum (54/100) factor scores. The current signal is BUY. A high-quality contact lens manufacturer, but currently trading at a full valuation with no direct macro tailwinds from our identified themes.
The Cooper Companies, Inc. is a global medical device company operating through two distinct segments: CooperVision, a leading manufacturer of contact lenses, and CooperSurgical, a provider of women's healthcare solutions. CooperVision holds a dominant position in specialty contact lenses, while CooperSurgical offers innovative products supporting fertility, diagnostics, and surgical procedures. The company's focus on high-growth, niche medical device markets, backed by strong R&D, provides a resilient business model in the healthcare sector.
| Price | $68.62 |
| Market Cap | $11.9B |
| P/E (TTM) | 30.86 |
| P/E (Forward) | 12.37 |
| Price/Book | 1.45 |
| Return on Equity | 4.9% |
| Return on Invested Capital | 5.9% |
| Debt/Equity | 33.20 |
| Gross Margin | 65.4% |
| Operating Margin | 20.8% |
| Revenue Growth | 6.2% |
| Free Cash Flow | $367M |
The Cooper Companies, Inc. operates in the Medical Instruments & Supplies industry, part of the Healthcare sector (United States).